Zimmer Biomet faces challenges amid uncertainties and recalled product, leading to potential downside risks and a volatile ...

As we can see, the Western Asset Investment Grade Income Fund currently has a yield that is rather unattractive when compared ...

The John Hancock Preferred Income Fund offers an 8.04% yield, but it trades at an 8.84% premium to NAV. Click here to read an ...

Organon acquires ROIV's Dermavant for $1.2B, expanding their dermatology portfolio and potentially increasing sales. Click ...

Bausch Health is rumored to be looking to sell its Bausch + Lomb business, which will ease bankruptcy concerns and upgrade ...

Steelcase Inc. stock dropped despite strong earnings, why it remains a good buy, and management's outlook. Read more on SCS ...

Lululemon has had recent product stumbles, indicating they may be losing their edge. See why I feel LULU stock is undervalued ...

Smartsheet (SMAR) stock drops 1.3% as COO leaves amid reports of potential $8 billion acquisition by Vista Equity and ...

White Mountains has a long-term track record of solid performance through market cycles, with 14% CAGR and strong ROEs. Read ...

Rocket Pharmaceuticals announced enrollment completion for phase 2 study using its gene therapy RP-A501 for treatment of male ...

Photronics Q3 results were disappointing, with revenue down 6% yoy and a miss on both GAAP and non-GAAP EPS. See why PLAB ...

The economy is good, but not great. But inflation expectations among younger and lower-income people are high. The ...